Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Public offering nets $7mm for Biocept

Executive Summary

Biocept Inc. (liquid biopsies for cancer) netted $7mm through the public sale of 6.25mm common shares at $1.20. Investors also received five-year warrants to purchase an additional 6.25mm shares at $1.20. Funds will support continued operations and business expansion including commercial strategy initiatives, completion of a physician portal for a pathology partnership, and the launch of a pharma partnership strategy.
Deal Industry
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Laboratory Testing Services
  • Services
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies